Top 7 China Medical Device Companies 2025
China's medical device market exceeded RMB 1.2 trillion in 2025, making it the world's second-largest medical device market after the US. Chinese medical device companies have achieved significant technological advancement in imaging, in-vitro diagnostics (IVD), surgical robotics, and cardiovascular devices, with growing export market share in emerging economies. The government's Made in China 2025 and domestic substitution policies continue to drive import replacement.
TL;DR: China's medical device market exceeds RMB 1.2T. Mindray leads with RMB 35B+ revenue across monitoring/imaging/IVD while United Imaging's uMRI and PET-CT systems match or exceed international competitors in image quality.
Top Companies
Mindray Medical (迈瑞医疗)
RMB 35B+ revenueMindray is China's largest medical device company with RMB 35B+ revenue, offering life support and monitoring, in-vitro diagnostics, and medical imaging systems. Its products are sold in 190+ countries, and it has achieved 50%+ domestic market share in patient monitoring and portable ultrasound.
United Imaging (联影医疗)
高端 imaging innovation leaderUnited Imaging develops advanced medical imaging systems including total-body PET-CT (uEXPLORER), 5.0T MRI, and CT scanners. Its uEXPLORER total-body PET-CT is the world's first and only FDA-approved total-body PET/CT system, revolutionizing oncology and neurology imaging.
MicroPort (微创医疗)
Surgical robotics + cardiovascularMicroPort is China's leading cardiovascular and surgical robotics company, with its Toumai surgical robot system competing with da Vinci in minimally invasive surgery. Its cardiovascular division produces drug-eluting stents, heart valves, and electrophysiology products, with growing international market presence.
SBF (圣湘生物)
Molecular diagnostics leaderSBF (Sansure Biotech) is China's leading molecular diagnostics company, providing nucleic acid detection platforms for infectious diseases, oncology, and genetic testing. Its platform technology enables rapid, multiplex molecular testing with 10,000+ hospitals and laboratories as customers.
Neusoft Medical (东软医疗)
CT + MRI pioneerNeusoft Medical is one of China's pioneering medical imaging companies, producing CT scanners, MRI systems, PET/CT, and X-ray equipment. It has installed 30,000+ imaging systems globally and holds significant market share in China's tier-2 and tier-3 hospitals with cost-effective, high-quality imaging solutions.
Allmed Medical (奥美医疗)
Orthopedic implants leaderAllmed Medical is China's leading orthopedic implant manufacturer, producing trauma fixation, joint replacement, and spine surgery products. It has achieved 30%+ domestic market share in trauma fixation devices and is expanding internationally with FDA-cleared products for the US market.
Edan Instruments (理邦仪器)
Point-of-care diagnosticsEdan Instruments specializes in point-of-care diagnostic devices including patient monitoring, ultrasound, ECG, and IVD analyzers. Its products serve 170+ countries with particular strength in maternal and fetal monitoring, holding 50%+ market share in China's obstetric ultrasound segment.
Comparison Table
| Company | Core Products | Revenue | Global Reach | Key Strength |
|---|---|---|---|---|
| Mindray | Monitoring, imaging, IVD | RMB 35B+ | 190+ countries | Full product line |
| United Imaging | PET-CT, MRI, CT | RMB 12B+ | 60+ countries | Total-body PET-CT |
| MicroPort | Robotics, cardiovascular | RMB 8B+ | 70+ countries | Toumai robot |
| SBF/Sansure | Molecular diagnostics | RMB 5B+ | 160+ countries | Infectious disease |
| Neusoft Medical | CT, MRI, X-ray | RMB 4B+ | 110+ countries | Cost-effective imaging |
| Allmed | Orthopedic implants | RMB 3B+ | 60+ countries | Trauma fixation |
| Edan | POC monitoring, ultrasound | RMB 2B+ | 170+ countries | Maternal/fetal |
Frequently Asked Questions
How big is China's medical device market?
China's medical device market exceeded RMB 1.2 trillion in 2024, growing at 15%+ annually. Key segments include IVD (25%), cardiovascular (15%), imaging (15%), orthopedics (10%), and surgical equipment (10%). The market is projected to reach RMB 2 trillion by 2028.
How competitive are Chinese medical devices globally?
Chinese devices are highly competitive in mid-range segments: Mindray monitors compete with Philips, United Imaging PET-CT matches Siemens, and MicroPort stents compete with Medtronic. In premium segments (high-field MRI, advanced robotics), Chinese products are approaching parity. Price advantage of 30-50% drives adoption in emerging markets.
What is China's medical device import substitution rate?
China's domestic substitution rate varies by segment: patient monitoring (80%+), ultrasound (70%+), CT (50%+), MRI (40%+), IVD reagents (60%+), high-end surgical robotics (20%+). The government targets 70%+ substitution in high-end devices by 2025 through procurement preferences and R&D subsidies.
Which Chinese medical device companies export the most?
Mindray leads with 40%+ revenue from exports (RMB 14B+), followed by Neusoft Medical (30%+ export) and Edan Instruments (50%+ export). Key export markets include Southeast Asia, Latin America, Middle East, and Africa, with growing penetration into European markets.
How is AI being used in Chinese medical devices?
AI is integrated into imaging (United Imaging's AI-enhanced CT/MRI reconstruction), monitoring (Mindray's AI-based early warning systems), IVD (SBF's AI-assisted molecular diagnostics), and surgical robotics (MicroPort's AI navigation). Chinese companies have 200+ AI medical device approvals, the most of any country.